Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Xehetasun bibliografikoak
Egile Nagusiak:	Isaacs, J, Clarke, A, Hazleman, B, Hale, G, Waldmann, H, Symmons, D
Formatua:	Conference item
Argitaratua:	2004

Antzeko izenburuak

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
nork: Isaacs, J, et al.
Argitaratua: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
nork: Isaacs, J, et al.
Argitaratua: (2005)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
nork: Isaacs, J, et al.
Argitaratua: (1998)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
nork: Isaacs, J, et al.
Argitaratua: (1992)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
nork: Isaacs, J, et al.
Argitaratua: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
nork: Kyle, V, et al.
Argitaratua: (1991)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
nork: Isaacs, J, et al.
Argitaratua: (2002)

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
nork: Lorenzi, A, et al.
Argitaratua: (2008)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
nork: Watts, R, et al.
Argitaratua: (1992)

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
nork: Isaacs, J, et al.
Argitaratua: (2001)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
nork: Kyle, V, et al.
Argitaratua: (1989)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
nork: Isaacs, J, et al.
Argitaratua: (1996)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
nork: Lawson, C, et al.
Argitaratua: (2005)

Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
nork: Morgan, A, et al.
Argitaratua: (1997)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
nork: Isaacs, J, et al.
Argitaratua: (1996)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
nork: Lockwood, C, et al.
Argitaratua: (1993)

CAMPATH-1H in inflammatory arthritis.
nork: Watts, R, et al.
Argitaratua: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
nork: Lockwood, C, et al.
Argitaratua: (1993)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
nork: Lockwood, C, et al.
Argitaratua: (1995)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
nork: Isaacs, J, et al.
Argitaratua: (1993)

The lymphocytotoxic effect of homoprobiotic bifidobacteria and lactobacilli autostrains
nork: I. P. Pogorelsky, et al.
Argitaratua: (2014-09-01)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
nork: Evgeny Lvovich Nasonov, et al.
Argitaratua: (2012-06-01)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
nork: Isaacs, J, et al.
Argitaratua: (1992)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
nork: Waldmann, H, et al.
Argitaratua: (1982)

Monoclonal-antibody therapy in systemic vasculitis.
nork: Mathieson, P, et al.
Argitaratua: (1990)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
nork: Dyer, M, et al.
Argitaratua: (1988)

BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO
nork: Isaacs, J, et al.
Argitaratua: (1995)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
nork: Isaacs, J, et al.
Argitaratua: (1995)

Advantages of rat monoclonal antibodies.
nork: Clark, M, et al.
Argitaratua: (1983)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
nork: Lockwood, C, et al.
Argitaratua: (1996)

Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies.
nork: Isaacs, J, et al.
Argitaratua: (1994)

Specificity of monoclonal antibody Campath-1.
nork: Hale, G, et al.
Argitaratua: (1988)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
nork: Xiao-Kai Chi, et al.
Argitaratua: (2023-03-01)

Induction of tolerance by monoclonal antibody therapy.
nork: Benjamin, R, et al.
Argitaratua: (1986)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
nork: Hale, G, et al.
Argitaratua: (1994)

A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis.
nork: Morgan, A, et al.
Argitaratua: (2008)

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
nork: Isaacs, J, et al.
Argitaratua: (1997)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
nork: Lim, S, et al.
Argitaratua: (1993)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
nork: Waldmann, H, et al.
Argitaratua: (2001)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
nork: Mathieson, P, et al.
Argitaratua: (1990)